BiomEdit

BiomEdit

Private
Fishers, IndianaHealthcare & Life Scienceshttps://www.biomedit.com

Last Round

Grant

Oct 23, 2025

Total Funding Raised

$63.6M

Company Overview

BiomEdit is an animal health company that develops a microbiome innovation platform to discover and create products that enhance animal protein production and improve livestock disease monitoring through microbiome-derived bioactive and engineered microbial medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Carbon Capture

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

animal health biotechengineered probioticsmicrobiome sciencesynthetic biology platformdesigner probioticsmethane reductionfeed additivescow burp techantibiotic alternativesengineered bacterialivestock healthanimal microbiomepoultry healthmicrobial engineeringAI for methane reductionvectored antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BiomEdit Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BiomEdit Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 23, 2025
Series BJul 16, 2025
GrantJul 16, 2025
GrantNov 1, 2023
Series AFeb 18, 2023

Key People

Founding team and executive leadership

Aaron Schacht

Chief Executive Officer And Board Director

Executive Team

Eric Young

Chief Financial Officer And Chief Business Officer

Executive Team

BiomEdit Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    Secured $2M in grant funding.

  • Jul 16, 2025

    $18.4M round closed.

BiomEdit Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BiomEdit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BiomEdit's valuation, stock price, and market status.

Firmographic Details

HeadquartersFishers, Indiana
Employee Range37
Year Founded2022
Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.